.jpg "Cryolife (NYSE: CRY)")
Today it was reported that the VP & CAO of Cryolife (CRY), Amy Horton, exercised options to sell 6,666 CRY shares at $6.12 a share, for a total transaction value of $194.2K.
In addition to Amy Horton, one other CRY executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cryolife’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $67.8 million and GAAP net loss of $1.73 million. In comparison, last year the company earned revenue of $52.83 million and had a GAAP net loss of $3.01 million. Currently, Cryolife has an average volume of 186.8K.
The insider sentiment on Cryolife has been negative according to 92 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the Medical Devices, and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products; On-X products; CardioGenesis cardiac laser therapy; PerClot; and PhotoFix.
